NOVADEL PHARMA INC (NVD) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 39 transactions totaling $4.1M, demonstrating a bullish sentiment with $4.1M in net insider flow. The most recent transaction on Dec 11, 2009 involved a purchase of 26,200 shares valued at $3.9K.
No significant insider buying has been recorded for NVD in the recent period.
No significant insider selling has been recorded for NVD in the recent period.
Based on recent SEC filings, insider sentiment for NVD is bullish with an Insider Alignment Score of 100/100 and a net flow of $4.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at NOVADEL PHARMA INC (NVD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading NVD stock, having executed 39 transactions in the past 90 days. The most active insider is Jay Moorin (Executive), who has made 2 transactions totaling $2.4M.
Get notified when executives and directors at NVD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2009 | B. Ratoff Steven | Executive | Purchase | 26,200 | $0.15 | $3.9K | |
| Dec 11, 2009 | B. Ratoff Steven | Executive | Purchase | 465,800 | $0.18 | $83.8K | |
| Dec 11, 2009 | B. Ratoff Steven | Executive | Purchase | 8,000 | $0.13 | $1.0K | |
| Dec 8, 2009 | B. Ratoff Steven | Executive | Purchase | 263,866 | $0.14 | $36.9K | |
| Dec 8, 2009 | B. Ratoff Steven | Executive | Purchase | 236,134 | $0.15 | $35.4K | |
| Feb 6, 2008 | E. B. Spicer Michael | Executive | Award | 150,000 | $N/A | $0 | |
| Feb 6, 2008 | H. Bergstrom David | Executive | Award | 150,000 | $N/A | $0 | |
| Feb 6, 2008 | M. Zodda Deni Phd | Executive | Award | 150,000 | $N/A | $0 | |
| Feb 6, 2008 | B. Ratoff Steven | Executive | Award | 300,000 | $N/A | $0 | |
| Aug 31, 2007 | E. Bonney Thomas | Executive | Purchase | 500 | $0.81 | $405 | |
| Aug 30, 2007 | E. Bonney Thomas | Executive | Purchase | 5,300 | $0.79 | $4.2K | |
| Aug 30, 2007 | F. Hamilton William Phd | Executive | Purchase | 4,000 | $0.80 | $3.2K | |
| Aug 30, 2007 | E. Bonney Thomas | Executive | Purchase | 5,300 | $0.79 | $4.2K | |
| Aug 29, 2007 | J. Baric Mark | Executive | Purchase | 4,900 | $0.80 | $3.9K | |
| Aug 28, 2007 | J. Baric Mark | Executive | Purchase | 100 | $0.69 | $69 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 33 | $4.1M | 100.0% |
Award(A) | 4 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at NOVADEL PHARMA INC are accumulating shares at an accelerated pace. With 12 insiders making 39 transactions totaling $4.1M in purchases versus $0 in sales, the net buying activity of $4.1M signals strong executive confidence. Jay Moorin (Executive) leads the buying activity with $2.4M in transactions across all time.